HER-2 Positive Breast Cancer Withdrawn Phase Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0042425 (HER-2 Positive Breast Cancer)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02102438Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast CancerTreatment